312 related articles for article (PubMed ID: 18854665)
21. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus.
Katz D; Rothstein R; Schned A; Dunn J; Seaver K; Antonioli D
Am J Gastroenterol; 1998 Apr; 93(4):536-41. PubMed ID: 9576444
[TBL] [Abstract][Full Text] [Related]
22. Surveillance in Barrett's esophagus: a failed premise.
Inadomi JM
Keio J Med; 2009 Mar; 58(1):12-8. PubMed ID: 19398879
[TBL] [Abstract][Full Text] [Related]
23. Development and Validation of a Model to Determine Risk of Progression of Barrett's Esophagus to Neoplasia.
Parasa S; Vennalaganti S; Gaddam S; Vennalaganti P; Young P; Gupta N; Thota P; Cash B; Mathur S; Sampliner R; Moawad F; Lieberman D; Bansal A; Kennedy KF; Vargo J; Falk G; Spaander M; Bruno M; Sharma P
Gastroenterology; 2018 Apr; 154(5):1282-1289.e2. PubMed ID: 29273452
[TBL] [Abstract][Full Text] [Related]
24. Helicobacter pylori colonization of Barrett's esophagus and its progression to cancer.
Wright TA; Myskow M; Kingsnorth AN
Dis Esophagus; 1997 Jul; 10(3):196-200. PubMed ID: 9280079
[TBL] [Abstract][Full Text] [Related]
25. Screening and Surveillance for Barrett's Esophagus: Is It Cost-Effective?
Inadomi JM; Saxena N
Dig Dis Sci; 2018 Aug; 63(8):2094-2104. PubMed ID: 29948571
[TBL] [Abstract][Full Text] [Related]
26. Endoscopic therapy of esophageal premalignancy and early malignancy.
Nealis TB; Washington K; Keswani RN
J Natl Compr Canc Netw; 2011 Aug; 9(8):890-9. PubMed ID: 21900219
[TBL] [Abstract][Full Text] [Related]
27. A Tissue Systems Pathology Assay for High-Risk Barrett's Esophagus.
Critchley-Thorne RJ; Duits LC; Prichard JW; Davison JM; Jobe BA; Campbell BB; Zhang Y; Repa KA; Reese LM; Li J; Diehl DL; Jhala NC; Ginsberg G; DeMarshall M; Foxwell T; Zaidi AH; Lansing Taylor D; Rustgi AK; Bergman JJ; Falk GW
Cancer Epidemiol Biomarkers Prev; 2016 Jun; 25(6):958-68. PubMed ID: 27197290
[TBL] [Abstract][Full Text] [Related]
28. Derivation of genetic biomarkers for cancer risk stratification in Barrett's oesophagus: a prospective cohort study.
Timmer MR; Martinez P; Lau CT; Westra WM; Calpe S; Rygiel AM; Rosmolen WD; Meijer SL; Ten Kate FJ; Dijkgraaf MG; Mallant-Hent RC; Naber AH; van Oijen AH; Baak LC; Scholten P; Böhmer CJ; Fockens P; Maley CC; Graham TA; Bergman JJ; Krishnadath KK
Gut; 2016 Oct; 65(10):1602-10. PubMed ID: 26104750
[TBL] [Abstract][Full Text] [Related]
29. Barrett's esophagus.
Falk GW
Gastrointest Endosc Clin N Am; 1994 Oct; 4(4):773-89. PubMed ID: 7812646
[TBL] [Abstract][Full Text] [Related]
30. [Barrett's esophagus: its diagnosis and management in Japan].
Amano Y; Azumi T
Nihon Rinsho; 2015 Jul; 73(7):1129-35. PubMed ID: 26165069
[TBL] [Abstract][Full Text] [Related]
31. [Gastroesophageal reflux disease and malignancy].
Richert Z; Robaszkiewicz M
Rev Prat; 2008 Sep; 58(13):1414-5, 1417, 1419-20. PubMed ID: 18924321
[TBL] [Abstract][Full Text] [Related]
32. [Barrett's esophagus and Helicobacter pylori].
Sakata H; Fujimoto K
Nihon Rinsho; 2005 Aug; 63(8):1383-6. PubMed ID: 16101226
[TBL] [Abstract][Full Text] [Related]
33. Barrett's esophagus: Macroscopic markers and the prediction of dysplasia and adenocarcinoma.
Hillman LC; Chiragakis L; Clarke AC; Kaushik SP; Kaye GL
J Gastroenterol Hepatol; 2003 May; 18(5):526-33. PubMed ID: 12702044
[TBL] [Abstract][Full Text] [Related]
34. Endoscopic management of Barrett's esophagus associated dysplasia and early esophageal cancer.
Amick A; Komanduri S
Minerva Gastroenterol Dietol; 2013 Mar; 59(1):25-39. PubMed ID: 23478241
[TBL] [Abstract][Full Text] [Related]
35. Outcome of esophageal adenocarcinoma detected during endoscopic biopsy surveillance for Barrett's esophagus.
Incarbone R; Bonavina L; Saino G; Bona D; Peracchia A
Surg Endosc; 2002 Feb; 16(2):263-6. PubMed ID: 11967675
[TBL] [Abstract][Full Text] [Related]
36. Reflux disease and Barrett's esophagus.
Haag S; Holtmann G
Endoscopy; 2003 Feb; 35(2):112-7. PubMed ID: 12561004
[TBL] [Abstract][Full Text] [Related]
37. Risk factors in the development of esophageal adenocarcinoma.
Pohl H; Wrobel K; Bojarski C; Voderholzer W; Sonnenberg A; Rösch T; Baumgart DC
Am J Gastroenterol; 2013 Feb; 108(2):200-7. PubMed ID: 23247577
[TBL] [Abstract][Full Text] [Related]
38. Barrett's esophagus.
Falk GW
Gastroenterology; 2002 May; 122(6):1569-91. PubMed ID: 12016424
[TBL] [Abstract][Full Text] [Related]
39. Helicobacter pylori eradication treatment and the risk of Barrett's esophagus and esophageal adenocarcinoma.
Doorakkers E; Lagergren J; Santoni G; Engstrand L; Brusselaers N
Helicobacter; 2020 Jun; 25(3):e12688. PubMed ID: 32175626
[TBL] [Abstract][Full Text] [Related]
40. Incidence of adenocarcinoma among patients with Barrett's esophagus.
Hvid-Jensen F; Pedersen L; Drewes AM; Sørensen HT; Funch-Jensen P
N Engl J Med; 2011 Oct; 365(15):1375-83. PubMed ID: 21995385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
